As of Feb 27
| -0.27 / -3.42%|
The 6 analysts offering 12-month price forecasts for LeMaitre Vascular Inc have a median target of 11.00, with a high estimate of 12.00 and a low estimate of 8.00. The median estimate represents a +44.36% increase from the last price of 7.62.
The current consensus among 6 polled investment analysts is to Buy stock in LeMaitre Vascular Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.